Chapter 21 Review Qs & Evolve Flashcards
- What is the goal of drug therapy for asthma and/or COPD?
A. To cure asthma or COPD B. To improve airflow and reduce symptoms C. To thicken bronchiolar cartilage and increase alveolar size D. To decrease alveolar recoil and improve contraction of bronchiolar smooth muscle
B
- Which drugs are long-acting beta agonists? (Select all that apply.)
A. budesonide (Pulmicort) B. formoterol (Foradil) C. ipratropium (Atrovent) D. levalbuterol (Xopenex) E. nedocromil (Tilade) F. salmeterol (Serevent) G. tiotropium (Spiriva)
B F
- Which beta-adrenergic agonist is most effective as a rescue drug?
A. Arformoterol (Brovana) B. Formoterol (Foradil) C. Levalbuterol (Xopenex) D. Salmeterol (Serevent)
C
- A patient who received a bronchodilator 20 minutes ago now has all of the following responses. For which one do you notify the prescriber immediately?
A. Change in oxygen saturation from 89% to 95% B. Bad taste in the mouth C. Chest pain on exertion D. Dryness of the mouth and throat
C
- Which symptoms or conditions are side effects of cholinergic antagonist drugs? Select all that apply.
A. Anorexia B. Blurred vision C. Constipation D. Diarrhea E. Sleepiness F. Urinary retention G. Watery eyes
B C F
- Which drug classes are used as therapy for pulmonary artery hypertension (PAH)? Select all that apply.
A. Endothelin-receptor antagonists B. Inhaled corticosteroids C. Mucolytics D. Phosphodiesterase inhibitors E. Long-acting beta agonists F. Prostacyclin agents G. Short-acting beta agonists H. Vitamin K antagonists
A D F H
- When a patient is prescribed an inhaled bronchodilator and an inhaled corticosteroid at the same time, why must he or she wait 5 minutes after using the bronchodilator before using the inhaled corticosteroid?
A. When the two drugs are taken one right after the other, the effects of both are reduced.
B. When the two drugs are taken one right after the other, the side effects are more severe.
C. Giving the bronchodilator first allows the inhaled corticosteroid to be more effective.
D. Giving the bronchodilator first reduces the risk for an allergic reaction to the inhaled corticosteroid.
C
- Which sign or symptom in a patient who is using a short-acting beta agonist (SABA) as a rescue drug indicates that he or she is using the inhaler very frequently?
A. Tremors B. Urinary incontinence C. Oral candidiasis (thrush) D. Widely dilated pupils of the eye
A
- A patient who has COPD asks what exactly guaifenesin (Mucinex) does to help him breathe better. What is your best answer?
A. “It thins the lining of your lung air sacs making it easier for oxygen to enter your body.” B. “It decreases inflammation and reduces your risk for lung infections.” C. “It suppressed your cough reflex so that you can breathe better while sleeping.” D. It thins your lung secretions making it easier for you to cough them out.”
D
- Which problem indicates that a patient may be excessively using his or her beclomethasone (QVAR) inhaler?
A. The presence of thick white cheesy material on the tongue and roof of the mouth
B. The onset of muscle cramps in the legs while at rest
C. The need to get up to urinate 3 to 4 times every night
D. The development of a dry, tickling cough
A
- What is the most important point to teach a patient using a long-acting beta agonist (LABA)?
A. Brush your teeth and rinse your mouth 3 times daily to prevent a bad taste. B. Take the drug daily as prescribed even when you have no symptoms. C. Use a reliable form of contraception while taking this drug. D. Keep the inhaler with you at all times.
B
- Which precaution should you teach a woman taking bosentan (Tracleer)?
A. Use strict aseptic technique while handling this drug.
B. Avoid drinking caffeine while on this drug.
C. Use a reliable form of contraception
D. Rinse your mouth 4 times daily
C
A nurse is performing an admission assessment on a patient admitted with a respiratory diagnosis. What respiratory disorder is actually a combination of two disorders?
Asthma
Chronic obstructive pulmonary disease (COPD)
Emphysema
Chronic bronchitis
Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) is a respiratory disorder that is a combination of chronic bronchitis and emphysema. Other less common respiratory disorders that involve the lung tissue rather than the airways and result in impairment of gas exchange are pulmonary artery hypertension (PAH) and pulmonary fibrosis Asthma, emphysema, and chronic bronchitis are not a combination of two disorders.
Why are mucolytics helpful in the management of chronic obstructive pulmonary disease (COPD)?
Mucus becomes less sticky and is easier to cough up.
Airways widen and air moves more freely through them.
Mucus-secreting cells are inhibited and less mucus is produced.
Less mucus is trapped in the alveoli, and they then have better recoil.
Mucus becomes less sticky and is easier to cough up.
Mucolytics break the connections holding the protein and mucus molecules together. This results in thinner, less sticky mucus that is easier to cough up.
A patient asks how prescribed corticosteroids help with her breathing. What is your best response?
“They are fast-acting bronchodilators that relax the muscles in your airway.”
“They prevent the bronchial muscles from getting tight.”
“They thin excess secretions in your lungs.”
“They reduce inflammation that narrows the airways.”
“They reduce inflammation that narrows the airways.”
Corticosteroid drugs are similar to natural cortisol that prevent or limit inflammation by slowing or stopping inflammatory mediator production. Corticosteroids are not fast-acting bronchodilators and do not relax muscles in the airway. They also do not prevent the bronchial muscles from getting tight. Mucolytics and not corticosteroids thin increased secretions in the airways.